title: Natriuretic peptides for perioperative management of cardiac surgery.
abstract: Atrial natriuretic peptide (carperitide) is used to treat heart failure in Japan, while brain natriuretic peptide (nesiritide) is employed in Europe/USA. Patients undergoing cardiac surgery have a complex underlying pathologic state that features increased levels of neurohumoral factors due to activation of the renin-angiotensin-aldosterone system and/or increased sympathetic activity. We considered that perioperative administration of carperitide could be beneficial for cardiac surgery patients, and we have conducted clinical investigations of its use. This article reviews the effects of natriuretic peptides in cardiac surgery patients based on our experience and on previous reports about perioperative management with carperitide or nesiritide.
authors.affiliation: The Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan. Electronic address: asezai.med@gmail.com.
authors.forename: Akira
authors.initials: A
authors.lastname: Sezai
authors.affiliation: The Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan.
authors.forename: Motomi
authors.initials: M
authors.lastname: Shiono
mesh_terms: D001281:Atrial Fibrillation / Q000517:prevention & control; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006801:Humans; D019990:Perioperative Care; D011652:Pulmonary Circulation
chemical_list: D002316:Cardiotonic Agents; C472955:NPPA protein, human; D009320:Atrial Natriuretic Factor
keywords: Atrial natriuretic peptide; Cardiac surgery; Natriuretic peptide; Postoperative management